← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aureogen Biosciences, Inc.
Kalamazoo, MI
$3,891,026
Total funding
5
Grants
Funding over time
peak $1.3M · FY2006–12$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,891,026 · 5
By mechanism
R44$2,460,182 · 1
R43$1,430,844 · 4
Investigators at Aureogen Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Antifungals by Engineering the AbA NRPS gene$682,676
R44 · FY2008 · AI
Novel Antifungals by Engineering the AbA NRPS gene$658,406
R44 · FY2007 · AI
Novel Antifungals by Engineering the AbA NRPS gene$637,619
R44 · FY2006 · AI
A Bacitracin derivative for systemic use$381,116
R43 · FY2007 · AI
Generation of novel HCV drugs through engineereing of the cssA gene$300,000
R43 · FY2009 · AI
Generation of novel HCV drugs through engineereing of the cssA gene$300,000
R43 · FY2008 · AI
Generation of novel drugs against drug resistant bacteria through engineering of$286,746
R43 · FY2008 · AI
Novel Antifungals by Engineering the AbA NRPS gene$240,904
R44 · FY2012 · AI
Novel Antifungals by Engineering the AbA NRPS gene$240,577
R44 · FY2011 · AI
Novel Antifungals by Engineering the AbA NRPS gene$162,982
R43 · FY2004 · AI